{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "2613394",
  "DateCompleted": {
    "Year": "1990",
    "Month": "03",
    "Day": "14"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "09",
    "Day": "08"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0192-0561",
      "JournalIssue": {
        "Volume": "11",
        "Issue": "8",
        "PubDate": {
          "Year": "1989"
        }
      },
      "Title": "International journal of immunopharmacology",
      "ISOAbbreviation": "Int J Immunopharmacol"
    },
    "ArticleTitle": "Interleukin-1-induced sleep and febrile responses differentially altered by a muramyl dipeptide derivative.",
    "Pagination": {
      "StartPage": "887",
      "EndPage": "893",
      "MedlinePgn": "887-93"
    },
    "Abstract": {
      "AbstractText": [
        "Muramyl dipeptide (N-acetylmuramyl-L-alanyl-D-isoglutamine; AcMur-L-Ala-D-iGln; MDP) is a somnogenic, pyrogenic, and immunoadjuvant component of bacterial cell wall peptidoglycan. It enhances the production of the cytokine interleukin 1 (IL-1) in vivo and in vitro; IL-1 itself is somnogenic and pyrogenic. The pyrogenic effects of IL-1 may be separated from its somnogenicity by the use of antipyretics. A methyl ester derivative of MDP (murametide; AcMur-L-Ala-D-Gln-alpha-methyl ester) blocks IL-1-induced fever, but induces IL-1 production/release. Therefore, the effects of murametide on IL-1-induced sleep and fever responses were determined. Rabbits were pretreated with intravenous injections of murametide 0, 30 or 60 min before intravenous injection of a pyrogenic/somnogenic dose of recombinant IL-1 beta (rIL-1 beta). Murametide alone produced no effects on sleep or brain temperatures. Murametide given simultaneously with rIL-1 beta potentiated increases of brain temperatures, whereas when there was a 60 min delay between the injection of murametide and rIL-1 beta, responses were similar to those induced by rIL-1 beta alone. Murametide given 30 min before rIL-1 beta, blocked the expected IL-1-induced fevers but not the rIL-1 beta-mediated increases of slow-wave sleep and decreases of rapid-eye-movements sleep. These results reinforce the conclusion that, in part, independent brain mechanisms are involved in the somnogenic and pyrogenic actions of IL-1."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Physiology and Biophysics, University of Tennessee, Memphis 38163."
          }
        ],
        "LastName": "Cady",
        "ForeName": "A B",
        "Initials": "AB"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Riveau",
        "ForeName": "G",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Chedid",
        "ForeName": "L",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Dinarello",
        "ForeName": "C A",
        "Initials": "CA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Johannsen",
        "ForeName": "L",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Krueger",
        "ForeName": "J M",
        "Initials": "JM"
      }
    ],
    "GrantList": [
      {
        "GrantID": "NS 25378",
        "Acronym": "NS",
        "Agency": "NINDS NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, U.S. Gov't, Non-P.H.S.",
      "Research Support, U.S. Gov't, P.H.S."
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Int J Immunopharmacol",
    "NlmUniqueID": "7904799",
    "ISSNLinking": "0192-0561"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Adjuvants, Immunologic"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Interleukin-1"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Pyrogens"
    },
    {
      "RegistryNumber": "53678-77-6",
      "NameOfSubstance": "Acetylmuramyl-Alanyl-Isoglutamine"
    },
    {
      "RegistryNumber": "79787-27-2",
      "NameOfSubstance": "N-acetylmuramyl-alanylglutamine methyl ester"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "administration & dosage",
        "analogs & derivatives",
        "pharmacology"
      ],
      "DescriptorName": "Acetylmuramyl-Alanyl-Isoglutamine"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Adjuvants, Immunologic"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Interactions"
    },
    {
      "QualifierName": [
        "chemically induced",
        "prevention & control"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "antagonists & inhibitors",
        "pharmacology"
      ],
      "DescriptorName": "Interleukin-1"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Pyrogens"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Rabbits"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Sleep"
    }
  ]
}